A. Blum

Widely applicable, extended flow cytometric stem cell enumeration panel for quality control of advanced cellular products

L. Bullinger, M. Streitz, A. Künkele, 2022, Scientific Reports.

Standardized assay for assessment of minimal residual disease in blood, bone marrow and apheresis from patients with plasma cell myeloma

S. Schlickeiser, M. Streitz, I. Blau, 2019, Scientific Reports.

ARDitox: platform for the prediction of TCRs potential off-target binding

L. Bunse, G. Mazzocco, S. Stachura, 2023, bioRxiv.

Standardized assay for assessment of minimal residual disease in blood, bone marrow and apheresis from patients with plasma cell myeloma

S. Schlickeiser, M. Streitz, I. Blau, 2019, Scientific Reports.

Identification of tumor-specific MHC ligands through improved biochemical isolation and incorporation of machine learning

O. Popp, R. Szatanek, M. Klatt, 2023, bioRxiv.

Creating an Innovative Artificial Intelligence–Based Technology (TCRact) for Designing and Optimizing T Cell Receptors for Use in Cancer Immunotherapies: Protocol for an Observational Trial

S. Kłęk, T. Kowalczyk, J. Bujak, 2023, JMIR research protocols.